Company Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME 11:35:21 2024-02-23 am EST 5-day change 1st Jan Change
11.5 EUR +4.31% Intraday chart for Grifols, S.A. +8.39% -25.62%

Business Summary

Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:

- products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries;

- diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;

- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;

- other (5.4%): primarily intermediate biological products and subcontracted manufacturing services.

Net sales are distributed geographically as follows: Spain (5.3%), European Union (11.7%), the United States and Canada (63.6%) and other (19.4%).

Number of employees: 24,000

Sales per Business

EUR in Million2021Weight2022Weight Delta
Biopharma
82.5 %
3,815 77.3 % 5,005 82.5 % +31.20%
Diagnostic
11.1 %
779 15.8 % 671 11.1 % -13.84%
Others
4.1 %
40 0.8 % 250 4.1 % +531.41%
Bio Supplies
2.4 %
226 4.6 % 146 2.4 % -35.30%
Intersegments
-0.1 %
-68 -1.4 % -9 -0.1 % -86.75%

Sales per region

EUR in Million2021Weight2022Weight Delta
United States and Canada
63.6 %
3,155 63.9 % 3,856 63.6 % +22.22%
Rest of World
19.4 %
872 17.7 % 1,176 19.4 % +34.86%
Rest of European Union
11.7 %
544 11.0 % 712 11.7 % +30.79%
Spain
5.3 %
362 7.3 % 321 5.3 % -11.53%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 Feb. 05
Director of Finance/CFO 67 06-12-31
Chairman 65 06-04-04
Chief Tech/Sci/R&D Officer - 98-12-31
Chief Tech/Sci/R&D Officer - 03-12-31
Chief Tech/Sci/R&D Officer 56 96-12-31
Director/Board Member 48 16-05-29
Director/Board Member 68 00-04-12
Director/Board Member 61 01-07-26
Investor Relations Contact 61 95-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 65 06-04-04
Director/Board Member 68 00-04-12
Director/Board Member 61 01-07-26
Director/Board Member 56 15-05-28
Director/Board Member 61 20-10-08
Director/Board Member 48 16-05-29
Director/Board Member - 19-05-23
Chief Tech/Sci/R&D Officer - 03-12-31
Director/Board Member - 22-06-09
Director/Board Member - 22-06-09

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 261,425,110 256,475,663 ( 98.11 %) 4,945,947 ( 1.892 %) 98.71 %
Stock B 1 426,129,798 422,181,768 ( 99.07 %) 3,944,430 ( 0.9256 %)

Shareholders

NameEquities%Valuation
39,183,692 9.195 % 432 M €
Scranton Enterprises BV
8.404 %
35,812,622 8.404 % 395 M €
Capital Research & Management Co. (World Investors)
8.137 %
34,675,522 8.137 % 382 M €
30,209,093 7.089 % 333 M €
Ralledor Holding Spain SL
6.154 %
26,224,374 6.154 % 289 M €
Caixabank Asset Management SGIIC SA
1.340 %
5,710,858 1.340 % 63 M €
Bestinver Gestión SA SGIIC
0.8807 %
3,752,897 0.8807 % 41 M €
Devon Equity Management Ltd.
0.6479 %
2,761,000 0.6479 % 30 M €
AG2R LA MONDIALE GESTION d'ACTIFS SA
0.6111 %
2,604,116 0.6111 % 29 M €
BNP Paribas Asset Management Belgium SA
0.6090 %
2,595,020 0.6090 % 29 M €
NameEquities%Valuation
Brandes Investment Partners LP
5.156 %
13,480,174 5.156 % 110 M €
HSBC Global Asset Management (France) SA
0.6180 %
1,615,511 0.6180 % 13 M €
SIA Funds AG
0.2799 %
731,761 0.2799 % 6 M €
Oddo BHF Asset Management SAS
0.2664 %
696,476 0.2664 % 6 M €
Devon Equity Management Ltd.
0.2618 %
684,481 0.2618 % 6 M €
Santander Private Banking Gestion SA SGIIC
0.2471 %
646,013 0.2471 % 5 M €
DNCA Finance SA
0.2054 %
536,996 0.2054 % 4 M €
State Street Global Advisors Ltd.
0.1790 %
468,057 0.1790 % 4 M €
Gescooperativo SA SGIIC
0.1699 %
444,201 0.1699 % 4 M €
GVC Gaesco Gestión SGIIC SA
0.1684 %
440,306 0.1684 % 4 M €
NameEquities%Valuation
Capital Research & Management Co. (World Investors)
7.569 %
19,787,525 7.569 % 159 M €
Millennium Management LLC
6.021 %
15,739,163 6.021 % 127 M €
Brandes Investment Partners LP
5.378 %
14,059,501 5.378 % 113 M €
Brandes Investment Partners LP
5.170 %
13,516,011 5.170 % 109 M €
Black Creek Investment Management, Inc.
3.539 %
9,251,618 3.539 % 74 M €
Flat Footed LLC
2.815 %
7,358,779 2.815 % 59 M €
Pictet Asset Management Holding SA
2.741 %
7,165,673 2.741 % 58 M €
First Trust Advisors LP
1.792 %
4,684,749 1.792 % 38 M €
Capital Research & Management Co. (Global Investors)
1.657 %
4,331,222 1.657 % 35 M €
Merrill Lynch International
1.610 %
4,207,933 1.610 % 34 M €
NameEquities%Valuation
Yousif Capital Management LLC
0.001549 %
13,202 0.001549 % 72 743 €
DSM Capital Partners LLC
0.000481 %
4,096 0.000481 % 22 569 €

Holdings

NameEquities%Valuation
437,069,656 6.49% 391,439,584 $

Company contact information

Grifols SA

Avinguda de la Generalitat, 152-158 Parc de Negocis Can Sant Joan

08174, Barcelona

+34 93 571 05 00

http://www.grifols.com
address Grifols, S.A.(GRF)

Group companies

NameCategory and Sector
Financial Conglomerates
Grifols India Healthcare Pvt Ltd.

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
11.5 EUR
Average target price
19.15 EUR
Spread / Average Target
+66.57%
Consensus
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer